Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol. (2017)
Attributed to:
Integrating innovative technologies for genotyping and phenotyping in stratified medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2016-015081
PubMed Identifier: 28674140
Publication URI: http://europepmc.org/abstract/MED/28674140
Type: Journal Article/Review
Volume: 7
Parent Publication: BMJ open
Issue: 6
ISSN: 2044-6055